Blood tests may spare breast cancer patients from unnecessary scans

NCT ID NCT04597580

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether simple blood tests can tell if a woman's metastatic breast cancer is stable, so she can skip some routine scans. About 97 women with ER-positive/HER2-negative cancer will give blood samples at each scan visit. The goal is to create a smart algorithm that uses these blood markers to safely decide when imaging is not needed.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for METASTATIC BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer breast carcinoma breast neoplasm estrogen-receptor positive breast cancer Her2-receptor negative breast cancer neoplasm Neoplasm Metastasis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Department of Oncology, Kalmar Hospital

    Kalmar, Sweden

  • Department of Oncology, Linköping University Hospital

    Linköping, Sweden

  • Department of Oncology, Ryhov Hospital

    Jönköping, Sweden

  • Department of Oncology, Sahlgrenska University Hospital

    Gothenburg, Sweden

  • Department of Oncology, Södersjukhuset

    Stockholm, Sweden

  • The Christie NHS Foundation Trust

    Manchester, M20 4BX, United Kingdom

  • Wigan Infirmary, Wrightington, Wigan and Leigh NHS Foundation Trust

    Wigan, United Kingdom